Prof. Kerstin Hellwig: The use of DMTs during pregnancy & breastfeeding

With multiple sclerosis (MS) disproportionately affecting women of childbearing age, breastfeeding is a high-agenda topic among the research and healthcare professional community. With diagnosis and treatment now occurring earlier on in the disease course, and an ever-expanding number of disease modifying therapies (DMTs) becoming available, the debate is intensifying.